Biodexa Pharmaceuticals plc American Depositary Shs (BDRX)
Nasdaq: BDRX · Pharmaceutical Preparations · Cardiff · filing with the SEC since 2015
Who runs Biodexa Pharmaceuticals plc American Depositary Shs
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Stamp Stephen Anthony
Chief Executive Officer. First filing Mar 2026, latest Mar 18, 2026, 0 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
6 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Stamp Stephen Anthony | Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Powell Fiona Mary | Chief Financial Officer | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Parker Stephen Barry | director | Mar 2026 | Mar 20, 2026 | none |
| De Vries Simon | director | Mar 2026 | Mar 18, 2026 | none |
| Merchant Ann Louise | director | Mar 2026 | Mar 18, 2026 | none |
| Turton Simon | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.